NCT05126875
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with two previous courses of radiotherapy for the same metastasis (e.g. SRS and WBRT); Patient has a target lesion greater than the equivalent of a 3 cm diameter
https://ClinicalTrials.gov/show/NCT05126875